Alzheimer's patients show elevated active meprin-β in brain and cerebrospinal fluid

AI Summary

Researchers at a Spanish and UMH joint neuroscience laboratory identified elevated levels of the protein meprin-β in the brain and cerebrospinal fluid of patients with Alzheimer's disease. The findings could contribute to understanding the molecular mechanisms of neurodegeneration.

A team from the Altered Molecular Mechanism in Alzheimer's Disease and Dementia laboratory, led by Javier Sáez Valero, a researcher at the Institute for Neurosciences (IN), a joint center of Miguel Hernández University of Elche (UMH) and the Spanish National Research Council (CSIC), has identified increased levels of the protein meprin-β in the brain and cerebrospinal fluid of people with Alzheimer's disease.